Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Research — Infrastructure and facilities costs by Quarter
Research — Infrastructure and facilities costs ($M) ($M)
Vertex Pharmaceuticals Research — Infrastructure and facilities costs: $63.6M in Q2 2026, up 1.4% from a year earlier. That is the highest of the 38 quarters on record here.
Where the Q2 2026 figure comes from
“|| Infrastructure costs | 63.6 | 62.7 | 1% | 125.6 | 120.3 | 4%”
Source: Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K MD&A (Research Expenses Disaggregation Table).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Vertex Pharmaceuticals Research — Infrastructure and facilities costs ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rd-res-infra
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.